227 related articles for article (PubMed ID: 17969783)
1. [Evaluation of symptoms in patients with benign prostatic hyperplasia].
Cornu JN; Rouprêt M
Prog Urol; 2007 Sep; 17(5 Suppl 1):1023-5. PubMed ID: 17969783
[TBL] [Abstract][Full Text] [Related]
2. Cultural and linguistic validation of questionnaires for use in international studies: the nine-item BPH-specific quality-of-life scale.
Boyle P
Eur Urol; 1997; 32 Suppl 2():50-2. PubMed ID: 9248816
[TBL] [Abstract][Full Text] [Related]
3. Significance of nocturia in the International Prostate Symptom Score for benign prostatic hyperplasia.
Homma Y; Yamaguchi T; Kondo Y; Horie S; Takahashi S; Kitamura T
J Urol; 2002 Jan; 167(1):172-6. PubMed ID: 11743299
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of naftopidil for nocturia and consequent sleep disturbance in patients with benign prostatic hyperplasia].
Iwaki H; Narita M; Soga H; Sakano Y; Konishi T; Okada Y
Hinyokika Kiyo; 2010 Apr; 56(4):209-13. PubMed ID: 20448444
[TBL] [Abstract][Full Text] [Related]
5. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
[TBL] [Abstract][Full Text] [Related]
6. [Impact of nocturia on sleep quality in patients with lower urinary tract symptoms suggesting benign prostatic hyperplasia (LUTS/BPH). The NocSu Study].
Hernández C; Estivill E; Cantalapiedra A
Actas Urol Esp; 2010 May; 34(5):450-9. PubMed ID: 20470718
[TBL] [Abstract][Full Text] [Related]
7. The importance of standardisation and validation of symptom scores and quality of life: the urologist's point of view.
O'Leary M
Eur Urol; 1997; 32 Suppl 2():48-9. PubMed ID: 9248815
[TBL] [Abstract][Full Text] [Related]
8. [Impact of nocturia on sleep efficiency in patients with benign prostatic hypertrophy].
Chartier-Kastler E; Leger D; Montauban V; Comet D; Haab F
Prog Urol; 2009 May; 19(5):333-40. PubMed ID: 19393539
[TBL] [Abstract][Full Text] [Related]
9. [Impact of prostatic symptoms in patients with prostatic benign hyperplasia].
Salinas Sánchez AS; Hernánez Millán IR; Segura Martín M; Lorenzo Romero JG; López Torres Hidalgo J; Vírseda Rodríguez JA
Arch Esp Urol; 2000 Apr; 53(3):212-24. PubMed ID: 10851726
[TBL] [Abstract][Full Text] [Related]
10. Circadian rhythm of blood pressure in patients with benign prostatic hyperplasia.
Turgut F; Bayrak O; Kanbay M; Ozkara A; Uz E; Bavbek N; Kargili A; Akcay A
Scand J Urol Nephrol; 2008; 42(1):47-52. PubMed ID: 17853012
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and predictive value of voiding diary data versus prostate volume, maximal free urinary flow rate, and Abrams-Griffiths number in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
van Venrooij GE; van Melick HH; Eckhardt MD; Boon TA
Urology; 2008 Mar; 71(3):469-74. PubMed ID: 18342189
[TBL] [Abstract][Full Text] [Related]
12. [Impact of nocturia on the daily life of patients with lower urinary tract symptoms due to benign prostatic hyperplasia].
Cornu JN; Rouprêt M
Prog Urol; 2007 Sep; 17(5 Suppl 1):1033-6. PubMed ID: 17969786
[TBL] [Abstract][Full Text] [Related]
13. Variability of the International Prostate Symptom Score in men with lower urinary tract symptoms.
O'Connor RC; Bales GT; Avila D; Gerber GS
Scand J Urol Nephrol; 2003; 37(1):35-7. PubMed ID: 12745741
[TBL] [Abstract][Full Text] [Related]
14. Change in urinary symptoms and quality of life in men with benign prostatic hyperplasia after transurethral resection of prostate.
Chalise PR; Agrawal CS
Nepal Med Coll J; 2007 Dec; 9(4):255-8. PubMed ID: 18298015
[TBL] [Abstract][Full Text] [Related]
15. Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice.
Vallancien G; Emberton M; Alcaraz A; Matzkin H; van Moorselaar RJ; Hartung R; Harving N; Elhilali M;
BJU Int; 2008 Apr; 101(7):847-52. PubMed ID: 18321317
[TBL] [Abstract][Full Text] [Related]
16. Correlation of the International Prostate Symptom Score bother question with the Benign Prostatic Hyperplasia Impact Index in a clinical practice setting.
O'Leary MP; Wei JT; Roehrborn CG; Miner M;
BJU Int; 2008 Jun; 101(12):1531-5. PubMed ID: 18445080
[TBL] [Abstract][Full Text] [Related]
17. Correlation of prostate volume with international prostate symptom score and quality of life in men with benign prostatic hyperplasia.
Agrawal CS; Chalise PR; Bhandari BB
Nepal Med Coll J; 2008 Jun; 10(2):104-7. PubMed ID: 18828432
[TBL] [Abstract][Full Text] [Related]
18. [Clinical evaluation of supplemental administration of flavoxate hydrochloride in benign prostatic hyperplasia patients with nocturia resistant to an alpha1-adrenoceptor blocker].
Kato S; Kusaka M; Shiroki R; Izumitani M; Asano H; Ooki T; Yanaoka M; Hoshinaga K
Hinyokika Kiyo; 2008 Mar; 54(3):173-7. PubMed ID: 18411771
[TBL] [Abstract][Full Text] [Related]
19. [Validation of the patient-administered Danish Prostate Symptom Score Schedule].
Hansen BJ; Flyger HL; Brasso K; Schou J; Nordling J; Andersen JT; Mortensen SO; Meyhoff HH; Walter S; Hald T
Ugeskr Laeger; 1997 Jan; 159(5):591-7. PubMed ID: 9045449
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib for treatment of nocturia caused by benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled study.
Falahatkar S; Mokhtari G; Pourreza F; Asgari SA; Kamran AN
Urology; 2008 Oct; 72(4):813-6. PubMed ID: 18692876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
